|
|
||||||||
disrupts distal lung differentiation
1 Department of Pediatrics and 3 Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, Virginia 22908; and 2 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 75390
The distal epithelium of the developing
lung exhibits high-level expression of protein phosphatase 2A (PP2A), a
vital signaling enzyme. Here we report the discovery that in the lung,
the PP2A regulatory subunit B56
is expressed in a discrete
developmental period, with the highest protein levels at embryonic day
(e) 17, but no detectable protein in the newborn or adult. By
in situ hybridization, B56
was highly expressed in the distal
epithelium of newly forming airways and in mesenchymal cells. In
contrast, expression of B56
was quite low in the bronchial
epithelium and vascular smooth muscle. Transgenic expression of B56
using the lung-specific promoter for surfactant protein C (SP-C)
resulted in neonatal death. Examination of lungs from SP-C-B56
transgenic e18 fetuses revealed proximal airways and normal blood
vessels, but the tissue was densely populated with epithelial-type
cells and was devoid of normal peripheral lung structure. A component of the Wnt signaling pathway,
-catenin, was developmentally
regulated in the normal lung and was absent in lung tissue from B-56
transgenic fetuses. We propose that B56
is expressed at a particular
stage of lung development to modulate PP2A action on the
Wnt/
-catenin signaling pathway during lung airway morphogenesis.
lung development; Wnt;
-catenin; PP2A
This article has been cited by other articles:
![]() |
K.-O. Larsen, B. Lygren, I. Sjaastad, K. A. Krobert, K. Arnkvaern, G. Florholmen, A.-K. R. Larsen, F. O. Levy, K. Tasken, O. H. Skjonsberg, et al. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A Cardiovasc Res, October 1, 2008; 80(1): 47 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Bos, S. H. Diks, J. C.H. Hardwick, K. V. Walburg, M. P. Peppelenbosch, and D. J. Richel Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/{beta}-catenin pathway activity Carcinogenesis, December 1, 2006; 27(12): 2371 - 2382. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky Activation of the Canonical Wnt Pathway during Genital Keratinocyte Transformation: A Model for Cervical Cancer Progression Cancer Res., July 15, 2005; 65(14): 6199 - 6206. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |